The Checklist is designed to provide CHWs, supervisors, and program managers (from NTPs, NGOs, CBOs, and others) with very practical ways to properly implement TB IC and to minimize risk of transmission within community residential settings, including families and households.
Drs. Jacques Grosset and Timothy Sterling will discuss the rationale for and potential new approaches to treatment of TB in HIV-infected individuals. Primary and secondary resistance of TB medications and the role of therapeutic drug monitoring for HIV-infected patients will be explored. The application of research to clinical practice will be highlighted.
The guidelines show how people with HIV can be protected from tuberculosis with regular, low-cost preventive medication. The guidelines present a set of recommendations that will help reduce TB disease in people living with HIV, their families and communities through a combination of screening for TB and provision of IPT.
Community health centers (CHCs) are important facilities which implement routine HIV testing consistent with the 2006 recommendations issued by the Centers for Disease Control and Prevention (CDC). This document provides an overview of general protocol elements for facility-based HIV testing and post-test counseling.
The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.
This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.
The case highlighted in this issue came from a state health department nurse who lived in the small town located on a large Great Plains Indian reservation where this case unfolded. It involved an extended family spanning 4 generations, all of whom lived in the same 3-bedroom house.
This guide aims to improve case detection, management, and outcomes of children with TB.
This December 2009 presentation aims to foster reflection on and a debate about the role of communication in addressing tuberculosis (TB). The authors propose a conceptual framework of communication and its relation to ethics, building from previous experience in order work against stigma and discrimination in health care contexts by developing the advocacy, communication, and social mobilisation (ACSM) model.
This fact sheet introduces the TB blood test, also called an Interferon Gamma Release Assay or IGRA.
The challenges of TB-HIV co-Infection are highlighted in this issue. Psychosocial aspects of HIV diagnosis and self-awareness are also discussed.
